Galectin Therapeutics (GALT) Enterprise Value (2010 - 2026)
Galectin Therapeutics' quarterly Enterprise Value came in at -$14.1 million in Q1 2026, down 89.75% year-on-year from -$137.5 million in Q1 2025, and up 20.43% quarter-over-quarter from -$17.7 million in Q4 2025.
Galectin Therapeutics has reported Enterprise Value for 17 years, with the latest figure at -$14.1 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 89.75% year-over-year to -$14.1 million; the trailing twelve-month figure through Mar 2026 stood at -$14.1 million (down 89.75% YoY), and the FY2025 full-year result was -$17.7 million, down 17.2% from the prior year.
- Enterprise Value for Q1 2026 stood at -$14.1 million, up from -$17.7 million in the prior quarter.
- The five-year high for Enterprise Value was -$7.4 million in Q1 2025, with the low at -$31.6 million in Q1 2022.
- Average Enterprise Value over 5 years is -$19.3 million, with a median of -$18.0 million recorded in 2023.
- Year-over-year, Enterprise Value jumped 68.45% in 2025 and slumped 89.75% in 2026.
- Tracing GALT's Enterprise Value over 5 years: stood at -$18.6 million in 2022, then slumped by 38.02% to -$25.7 million in 2023, then jumped by 41.08% to -$15.1 million in 2024, then declined by 17.2% to -$17.7 million in 2025, then increased by 20.43% to -$14.1 million in 2026.
- The last three Enterprise Value figures came in at -$14.1 million (Q1 2026), -$17.7 million (Q4 2025), and -$11.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - | -14.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.10 Mn |
| Dec 31, 2025 | -17.72 Mn |
| Sep 30, 2025 | -11.53 Mn |
| Jun 30, 2025 | -13.77 Mn |
| Mar 31, 2025 | -7.43 Mn |
| Sep 30, 2024 | -27.06 Mn |
| Jun 30, 2024 | -25.60 Mn |
| Mar 31, 2024 | -23.56 Mn |
| Dec 31, 2023 | -25.66 Mn |
| Sep 30, 2023 | -20.36 Mn |
| Jun 30, 2023 | -17.97 Mn |
| Mar 31, 2023 | -17.80 Mn |
| Sep 30, 2022 | -15.83 Mn |
| Jun 30, 2022 | -24.18 Mn |
| Mar 31, 2022 | -31.61 Mn |
| Sep 30, 2021 | -36.60 Mn |
| Jun 30, 2021 | -31.60 Mn |
| Mar 31, 2021 | -20.76 Mn |
| Dec 31, 2020 | -27.14 Mn |
| Sep 30, 2020 | -32.56 Mn |
| Jun 30, 2020 | -40.77 Mn |
| Mar 31, 2020 | -43.33 Mn |
| Dec 31, 2019 | -47.48 Mn |
| Sep 30, 2019 | -50.34 Mn |
| Jun 30, 2019 | -52.04 Mn |
| Mar 31, 2019 | -6.97 Mn |
| Dec 31, 2018 | -8.25 Mn |
| Sep 30, 2018 | -10.14 Mn |
| Jun 30, 2018 | -10.50 Mn |
| Mar 31, 2018 | -3.99 Mn |
| Dec 31, 2017 | -3.05 Mn |
| Sep 30, 2017 | -6.96 Mn |
| Jun 30, 2017 | -9.13 Mn |
| Mar 31, 2017 | -13.64 Mn |
| Dec 31, 2016 | -15.36 Mn |
| Sep 30, 2016 | -14.34 Mn |
| Jun 30, 2016 | -16.25 Mn |
| Mar 31, 2016 | -20.60 Mn |
| Dec 31, 2015 | -24.10 Mn |
| Sep 30, 2015 | -21.32 Mn |
| Jun 30, 2015 | -26.36 Mn |
| Mar 31, 2015 | -29.35 Mn |
| Dec 31, 2014 | -29.13 Mn |
| Sep 30, 2014 | -31.20 Mn |
| Jun 30, 2014 | -34.42 Mn |
| Mar 31, 2014 | -36.59 Mn |
| Dec 31, 2013 | -10.49 Mn |
| Sep 30, 2013 | -9.72 Mn |
| Jun 30, 2013 | -5.10 Mn |
| Mar 31, 2013 | -7.02 Mn |
| Dec 31, 2012 | -9.36 Mn |
| Sep 30, 2012 | -11.06 Mn |
| Jun 30, 2012 | -13.13 Mn |
| Mar 31, 2012 | -12.57 Mn |
| Dec 31, 2011 | -4.24 Mn |
| Sep 30, 2011 | -5.31 Mn |
| Jun 30, 2011 | -5.78 Mn |
| Mar 31, 2011 | -6.95 Mn |
| Dec 31, 2010 | -4.23 Mn |
| Sep 30, 2010 | -2.81 Mn |
| Jun 30, 2010 | -2.86 Mn |